(Q41142601)

27 September 2017

1 reference

title

Activated clotting time versus activated partial thromboplastin time for therapeutic monitoring of heparin (English)

1 reference

partial thromboplastin time

27 September 2017

1 reference

R J Simko

1

1 reference

27 September 2017

F F Tsung

series ordinal

2

1 reference

27 September 2017

E J Stanek

series ordinal

3

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

Annals of Pharmacotherapy

27 September 2017

1 reference

27 September 2017

29

1 reference

27 September 2017

1015-21; quiz 1061

1 reference

27 September 2017

10

1 reference

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

27 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Reactivation of unstable angina after the discontinuation of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Heparin pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: magnitude and predictability of interindividual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Effect of clot-detection methods and reagents on activated partial thromboplastin time (APTT). Implications in heparin monitoring by APTT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Cardioprotective effects of ischemic preconditioning can be recaptured after they are lost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502901012

10.1177/106002809502901012

21 January 2018

Identifiers

DOI

0 references

1 reference